The human strain: can mpox be contained?

When Alexis de Tocqueville visited America from France in 1831 he saw a new kind of society. Not just a country, but an idea that would change the world. His book “Democracy in America” was a big influence on later generations of writers and thinkers, including The Economist’s US ...  Show more

Andy Burnham won a by-election he needed in order to challenge Sir Keir Starmer, Britain’s prime minister. We look at the path ahead for him. The Iran deal seemingly promises a financial windfall for the country and its regime—one that its battered economy sorely needs. And the m ...  Show more

Mpox is spreading fast across Africa, yet public information campaigns are scant and vaccines in short supply. Is a new pandemic in the offing? Strategists are pondering a new potential threat from Russia: the possibility that it could detonate a nuclear weapon in space (09:42). ...  Show more

America’s health secretary, RFK Jr, is known for his opposition to vaccines, particularly mRNA jabs, that have the potential to treat a large swathe of diseases. Slashing funding will have long term implications beyond America. Our correspondent visits Britain’s biggest and newes ...  Show more

Even as Western countries band together to condemn Israel’s actions, aid remains at a trickle and the war is expanding into a central-Gazan city. We ask how the horrors might end. As with many technologies before it, many worry artificial intelligence will ultimately dumb down it ...  Show more

Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean a ...  Show more